ACBD3抗体,Rabbit Monoclonal ACBD3 Antibody
  • ACBD3抗体,Rabbit Monoclonal ACBD3 Antibody
  • ACBD3抗体,Rabbit Monoclonal ACBD3 Antibody
  • ACBD3抗体,Rabbit Monoclonal ACBD3 Antibody

ACBD3抗体;ACBD3 Antibody—艾普蒂 新品

价格 询价
包装 20μl 50μl 100μl
最小起订量 1μl
发货地 上海
更新日期 2025-05-30
QQ交谈 微信洽谈

产品详情

中文名称:ACBD3抗体英文名称:Rabbit Monoclonal ACBD3 Antibody
品牌: 艾普蒂产地: 武汉
保存条件: Stored at -20°C for 8455 year. Avoid repeated freeze / thaw cycles.产品类别: 抗体
重组: 应用: WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性: Human,Mouse,Rat 宿主: Rabbit
偶联物: 靶点: ACBD3
2025-05-30 ACBD3抗体 Rabbit Monoclonal ACBD3 Antibody 20μl/RMB;50μl/RMB;100μl/RMB 艾普蒂 武汉 Stored at -20°C for 8455 year. Avoid repeated freeze / thaw cycles. 抗体

验证与应用

应用及物种
WB咨询技术 Human,Mouse,Rat
IF咨询技术 Human,Mouse,Rat
IHC咨询技术 Human,Mouse,Rat
ICC技术咨询 Human,Mouse,Rat
FCM咨询技术 Human,Mouse,Rat
Elisa咨询技术 Human,Mouse,Rat
   

产品详情

AliasesACBD3; GCP60; GOCAP1; GOLPH1; PAP7;;GCP60
WB Predicted band sizeCalculated MW: 61 kDa ; Observed MW: 70 kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenA synthesized peptide derived from human GCP60
FormulationPurified antibody in PBS with 0.05% sodium azide,0.05% BSA and 50% glycerol.

+ +

  •  

     

       All lanes use the Antibody at 1:1K dilution for 1 hour at room temperature.    


  •  

     

       All lanes use the Antibody at 1:1K dilution for 1 hour at room temperature.    


           

参考文献

以下是关于ACBD3抗体的3篇参考文献示例(文献信息为模拟示例,供参考):

---

1. **文献名称**: *"ACBD3 is required for Golgi apparatus structure and function in mammalian cells"*

**作者**: Shibata Y. et al.

**摘要**: 研究利用ACBD3特异性抗体,通过免疫荧光和免疫沉淀技术,揭示了ACBD3在维持高尔基体结构和调控膜运输中的关键作用。实验表明,ACBD3缺失导致高尔基体碎片化并影响蛋白质分泌。

2. **文献名称**: *"ACBD3 interacts with hepatitis C virus NS5A protein and facilitates viral replication"*

**作者**: Dereeper A. et al.

**摘要**: 通过免疫共沉淀(Co-IP)结合ACBD3抗体,本研究证实ACBD3与丙肝病毒NS5A蛋白直接相互作用,促进病毒复制复合体的组装,为抗病毒靶点开发提供了依据。

3. **文献名称**: *"Prognostic value of ACBD3 overexpression in hepatocellular carcinoma"*

**作者**: Deng L. et al.

**摘要**: 采用ACBD3抗体进行免疫组化分析,发现ACBD3在肝癌组织中高表达,且与患者不良预后显著相关,提示其可作为潜在肿瘤标志物。

4. **文献名称**: *"ACBD3 as a biomarker for peroxisome-ER contact sites in neurodegenerative diseases"*

**作者**: Reinhard T. et al.

**摘要**: 利用ACBD3抗体标记细胞器接触位点,发现ACBD3在阿尔茨海默病模型中参与过氧化物酶体-内质网互作异常,为神经退行性病变机制研究提供新方向。

---

**说明**:以上文献为示例性内容,实际文献需通过学术数据库(如PubMed、Web of Science)检索确认。若需具体文章,建议以“ACBD3 antibody”或“ACBD3 function”为关键词进一步查询。

       

背景信息

ACBD3 (Acyl-CoA-binding domain-containing protein 3) is a ubiquitously expressed scaffolding protein involved in maintaining Golgi apparatus structure and regulating intracellular membrane trafficking. It belongs to the ACBD protein family, characterized by an N-terminal acyl-CoA-binding domain that interacts with lipids, and a C-terminal Golgi dynamics (GOLD) domain mediating protein-protein interactions. ACBD3 plays a critical role in organizing membrane contact sites between the Golgi and other organelles, such as mitochondria and peroxisomes. It also interacts with phosphoinositide kinases (e.g., PI4KIIIβ) to regulate phosphoinositide metabolism, influencing vesicle formation and signaling pathways.

ACBD3 antibodies are essential tools for studying its localization, expression, and molecular interactions. They are widely used in techniques like Western blotting, immunofluorescence, and immunoprecipitation to investigate ACBD3's role in viral replication (e.g., picornaviruses exploit ACBD3 for replication organelle formation), lipid homeostasis, and diseases like cancer and neurodegenerative disorders. Polyclonal antibodies are often raised against recombinant ACBD3 fragments, ensuring specificity for human, mouse, or rat homologs. Recent studies highlight ACBD3's involvement in cell proliferation and apoptosis regulation, making its antibodies valuable for exploring therapeutic targets. Validation via knockout/knockdown controls is recommended due to potential cross-reactivity with homologous proteins.

       
关键字: ACBD3抗体;ACBD3;ACBD3 Antibody;

公司简介

生物技术有限公司
成立日期 2024-07-02 (2年) 注册资本 20万人民币
员工人数 1-10人 年营业额 ¥ 100万以内
主营行业 抗体,植物生物技术,细胞培养,蛋白组学 经营模式 贸易,工厂,试剂,定制,服务
  • 上海切尔齐生物科技有限公司
VIP 1年
  • 公司成立:2年
  • 注册资本:20万人民币
  • 企业类型:有限责任公司(自然人投资或控股)
  • 主营产品:生物试剂
  • 公司地址:青浦
询盘

ACBD3抗体;ACBD3 Antibody—艾普蒂相关厂家报价

产品名称 价格   公司名称 报价日期
询价
VIP4年
维百奥(北京)生物科技有限公司
2025-12-29
¥1800
VIP2年
费雪(杭州)医学研究有限公司
2026-01-05
询价
上海华盈生物医药科技有限公司
2026-01-13
内容声明:
以上所展示的信息由商家自行提供,内容的真实性、准确性和合法性由发布商家负责。 商家发布价格指该商品的参考价格,并非原价,该价格可能随着市场变化,或是由于您购买数量不同或所选规格不同而发生变化。最终成交价格,请咨询商家,以实际成交价格为准。请意识到互联网交易中的风险是客观存在的
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 |投诉中心
Copyright © 2008 ChemicalBook 京ICP备07040585号  京公海网安备110108000080号  All rights reserved.